Prevention of catheter-related deep vein thrombosis with nadroparin in hemato-oncology patients treated with high dose chemotherapy
Completed
- Conditions
- Hemato-oncology patients with deep vein thrombosisCirculatory SystemDeep vein thrombosis
- Registration Number
- ISRCTN29686154
- Lead Sponsor
- Academic Medical Center (AMC) (The Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Central venous catheter
2. Indication for high dose chemotherapy (acute myeloid leukaemia [AML], acute lymphoblastic leukaemia [ALL], myelodysplasia-refractory anemia with excess of blasts in transformation [MDS-RAEB], multiple mye!oma [MM])
3. Informed consent
Exclusion Criteria
1. Current anticoagulant therapy
2. Allergy for contrastmedia
3.Promyelocytic leukemia (AML-M3)
4. Bleeding tendency
5. Renal failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Asymptomatic and symptomatic catheter-related deep vein thrombosis proven by ultrasound or venography
- Secondary Outcome Measures
Name Time Method 1. Catheter-related infections<br>2. Bleeding complications